These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37622223)

  • 1. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case-control study.
    Şenel E; Salmanoğlu M; Solmazgül E; İnal BB
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1811-1814. PubMed ID: 37622223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: a case-control study.
    Senel E; Salmanoğlu M; Solmazgül E; Berçik İnal B
    J Eur Acad Dermatol Venereol; 2011 Dec; ():. PubMed ID: 22188364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrochordons as a cutaneous sign of metabolic syndrome: a case-control study.
    Shah R; Jindal A; Patel N
    Ann Med Health Sci Res; 2014 Mar; 4(2):202-5. PubMed ID: 24761238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between acrochordons and the components of metabolic syndrome.
    Akpinar F; Dervis E
    Eur J Dermatol; 2012; 22(1):106-10. PubMed ID: 22063265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case-control study.
    Rasi A; Soltani-Arabshahi R; Shahbazi N
    Int J Dermatol; 2007 Nov; 46(11):1155-9. PubMed ID: 17988334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrochordon and impaired carbohydrate metabolism.
    Demir S; Demir Y
    Acta Diabetol; 2002 Jun; 39(2):57-9. PubMed ID: 12120914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation of Syzygium cumini seed powder prevented obesity, glucose intolerance, hyperlipidemia and oxidative stress in high carbohydrate high fat diet induced obese rats.
    Ulla A; Alam MA; Sikder B; Sumi FA; Rahman MM; Habib ZF; Mohammed MK; Subhan N; Hossain H; Reza HM
    BMC Complement Altern Med; 2017 Jun; 17(1):289. PubMed ID: 28578702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased insulin secretion and insulin sensitivity are associated with liver function in subjects with fasting glucose between 100 and 109 mg/dL in Taiwanese population.
    Hsiao JY; Wang CL; Hsia PJ; Hsieh MC; Hsin SC; Lin KD; Shin SJ
    Pancreas; 2007 Nov; 35(4):343-7. PubMed ID: 18090240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cilazapril therapy on glucose and lipid metabolism in patients with hypertension.
    Shionoiri H; Takasaki I; Naruse M; Nagamoti I; Himeno H; Ito T; Ohtomi S; Hata T; Shindo K; Mikami H
    Clin Ther; 1995; 17(6):1126-35. PubMed ID: 8750404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.
    Sheu WH; Jeng CY; Young MS; Le WJ; Chen YT
    Am J Med Sci; 2000 Feb; 319(2):84-8. PubMed ID: 10698091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study.
    Matrozova J; Steichen O; Amar L; Zacharieva S; Jeunemaitre X; Plouin PF
    Hypertension; 2009 Apr; 53(4):605-10. PubMed ID: 19221213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Abnormalities in Patients With Cushing's Disease and Its Relationship With Impaired Glucose Metabolism.
    Sun X; Feng M; Lu L; Zhao Z; Bao X; Deng K; Yao Y; Zhu H; Wang R
    Front Endocrinol (Lausanne); 2020; 11():600323. PubMed ID: 33633684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):853-64. PubMed ID: 15270403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felodipine therapy may not alter glucose and lipid metabolism in hypertensives. Felodipine Multicenter Prospective Study Group in Japan.
    Shionoiri H; Takizawa T; Ohyama Y; Ishii J; Katayama S; Nagasawa T; Kitamoto K; Nagasawa K; Hariya Y; Sato R
    Hypertension; 1994 Jan; 23(1 Suppl):I215-9. PubMed ID: 8282362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte telomere length is inversely associated with post-load but not with fasting plasma glucose levels.
    Khalangot M; Krasnienkov D; Vaiserman A; Avilov I; Kovtun V; Okhrimenko N; Koliada A; Kravchenko V
    Exp Biol Med (Maywood); 2017 Apr; 242(7):700-708. PubMed ID: 28299976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
    Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
    Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.